Hospital Exemption for Advanced Therapy Medicinal Products: Issue in Application in the European Union Member States.
Curr Stem Cell Res Ther
; 12(1): 45-51, 2017.
Article
en En
| MEDLINE
| ID: mdl-27412678
Regulation (EC) 1394/2007 of the European Parliament and the Council on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004 allowed the use of non - authorized advanced therapy medicinal products under the certain circumstances. This socalled hospital exemption rule needs to be applied in the each Member State of the European Union individually and for this purpose Member States should provide national procedures and control measures. The aim of this article is to clear up the criteria for hospital exemption listed in Regulation (EC) 1394/2007 and to contrast the difference in implementing hospital exemption rule into national legal regimes on examples of the United Kingdom, Lithuania and Poland.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Terapia Genética
/
Ingeniería de Tejidos
/
Terapias en Investigación
/
Unión Europea
/
Tratamiento Basado en Trasplante de Células y Tejidos
/
Hospitales
/
Legislación Hospitalaria
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Revista:
Curr Stem Cell Res Ther
Asunto de la revista:
TERAPEUTICA
Año:
2017
Tipo del documento:
Article
Pais de publicación:
Emiratos Árabes Unidos